Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vixiar Medical develops non-invasive, cost-effective devices and systems for monitoring cardiopulmonary diseases.
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
N5 Sensors develops a chemical sensor technology that detects harmful chemicals mixed in the air.
AudioOne develops a personal radio platform for users to access music, news, and podcasts.
Balance Theory provides the knowledge sharing and collaboration platform purpose-built for cybersecurity.
The LaunchPort is a medtech manufacturing accelerator that provides clinical trial and post-market device history file management.
Nodal Therapeutics is a venture-backed startup developing next-generation antigen-specific tolerance technology to stop autoimmune disease.
Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.
Your automated product security engineer
Din Din is an online marketplace that offers meal ordering, meal preparation, payment processing, and meal delivery services.
JuneBrain is an early start-up company that helps multiple sclerosis patients through the power of telemedicine.
Novel Microdevices is a medical device startup that develops a handheld point-of-care medical device to facilitate molecular diagnostics.
Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.
greatEvent is an online event booking platform to search hotels and service providers.
Relai.ai focuses on making AI models more dependable for critical applications.
Target climate action. Measure impact.
Givhero creates socially responsible and connected communities through health and well-being.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
BLOCKsyncop is developing a non-invasive real-time tool for the anesthesiologist.
Fostering a healthy online community, one post at a time!
Foretrace’s patent-pending Total Recon™ Threat Exposure Management engine detects data exposure and alerts you before it results in breaches
They help you translate new ideas, science and technology into a competent business structure and strategy.
Digital management system for pet service providers
ARMR Systems designs wearable first response hemorrhage control solutions to stop the bleeding anytime, anywhere.
TEDCO has invested in 178 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TEDCO's top investment sectors include Biotechnology, Health Care, Medical, Medical Device, Therapeutics. The firm invests across 53 different industry categories.
Among tracked funding rounds, Secretome Therapeutics received $30.0M in a Series A round. TEDCO's total known invested capital is $365.0M.
TEDCO's average investment size is $2.4M across its portfolio of 178 companies.
Recent TEDCO portfolio additions include Vixiar Medical, Veralox Therapeutics, N5 Sensors, AudioOne, Balance Theory. These companies were founded in 2020 or later.